DNAH5 Gene Primary Ciliary Dyskinesia Type 3 NGS Genetic DNA Test
Introduction to the Test
The DNAH5 Gene Primary Ciliary Dyskinesia Type 3 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with primary ciliary dyskinesia (PCD). PCD is a rare genetic disorder that affects the cilia, the tiny hair-like structures that help move mucus out of the lungs, leading to respiratory issues and other complications. Understanding your genetic predisposition to this condition is crucial for early diagnosis and effective management.
What the Test Measures
This test specifically detects mutations in the DNAH5 gene, which plays a vital role in the structure and function of cilia. By analyzing your genetic material, the test can confirm or rule out the presence of mutations that may contribute to PCD.
Who Should Consider This Test
Individuals experiencing symptoms such as chronic respiratory infections, reduced fertility, or unexplained lung conditions should consider this test. Additionally, those with a family history of PCD or related conditions may also benefit from genetic testing to assess their risk.
Benefits of Taking the Test
- Early diagnosis of primary ciliary dyskinesia, leading to timely treatment.
- Informed family planning through understanding genetic risks.
- Access to specialized care and management strategies for respiratory health.
Understanding Your Results
Once the test is completed, your results will be interpreted by a qualified genetic counselor or medical professional. They will help you understand the implications of your results and guide you in making informed decisions regarding your health and any necessary lifestyle adjustments.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 400,000 NGN | 560,000 NGN |
Book the Test
Ready to gain insights into your genetic health? Book the DNAH5 Gene Primary Ciliary Dyskinesia Type 3 NGS Genetic DNA Test today! For inquiries or to schedule an appointment, please call or WhatsApp us at +2348077798758.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: Clinical history of the patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A genetic counseling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS19.
Specialty: ENT Doctor
Department: Genetics
Method: NGS Technology
Disease Type: Ear Nose Throat Disorders
